• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Aurobindo Pharma Ltd.
    31 Jul 2025
    1090.00
    -0.64%
    Lannett deal gives Aurobindo Pharma a strategic edge amid US tariff concerns
    Business Line
    The acquisition brings cost synergies, SG&A rationalisation, and access to government procurement programs due to the local footprint.
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
    logo
    Orchid Pharma Ltd.
    31 Jul 2025
    721.45
    -2.18%
    Orchid Pharma hits 5% upper circuit in trade; why is the stock in demand?
    Business Standard
    Orchid Pharma shares were locked in a 5 per cent upper circuit at 740.1 per share on BSE; here's why
    Copy LinkShare onShare on Share on Share on
    Orchid Pharma Ltd. has lost -47.39% in the last 1 Year
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    30 Jul 2025
    1670.10
    0.04%
    JB Pharma Q1 results: Net profit up at 14% to 202 cr, revenue rises 9%
    Business Standard
    JB Chemicals & Pharmaceuticals Ltd on Wednesday reported a 14 per cent rise in net profit to Rs 202 crore in the June quarter. The company had posted a net profit of Rs 177 crore in the corresponding period of the previous fiscal year, JB Chemicals & Pharmaceuticals (JB Pharma) said in a regulatory filing. Revenue in the first quarter stood at Rs 1,094 crore as against Rs 1,004 crore in the same period a year ago, up 9 per cent, it added. "The domestic business recorded approximately 14 per cent value growth. This was driven by acute and chronic segments, including our ophthalmology portfolio. Our major brands & their franchises are also performing well," JB Pharma CEO and Wholetime Director, Nikhil Chopra said. He further said, "The CDMO (contract development and manufacturing organisation) business momentum is likely to sustain in coming quarters." The company said its domestic formulations business recorded revenue of Rs 678 crore as against Rs 595 crore in the first...
    Copy LinkShare onShare on Share on Share on
    J B Chemicals & Phar.. has an average target of 2030.00 from 2 brokers.
    logo
    Aurobindo Pharma Ltd.
    30 Jul 2025
    1090.00
    -0.64%
    Aurobindo Pharma to acquire US-based drug-makerLannett Company for 2185 cr
    Business Line
    Lannett has been is a US based manufacturer and supplier of superior quality, complex generic pharmaceuticals
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. is trading below its 100 day SMA of 1120.1
    logo
    Mankind Pharma Ltd.
    30 Jul 2025
    2482.90
    -1.71%
    Mankind Pharma Q1 Results Preview: Revenue Likely To Rise, Net Profit May Decline
    Mankind Pharma Q1 Results Preview: Revenue Likely To Rise, Net Profit May Decline
    NDTV Profit
    As per Bloomberg estimates, Mankind Pharma's consolidated revenue for the first quarter is expected to rise year-on-year to Rs 3,605.53 crore.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.
    logo
    Wockhardt Ltd.
    29 Jul 2025
    High Loss High Volume
    1336.50
    -9.46%
    How Wockhardt's bet on multi-drug resistant infections is paying off
    Business Standard
    In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 171 to 186 in Jun 2025 qtr.
    logo
    AstraZeneca Pharma India Ltd.
    29 Jul 2025
    8811.50
    -2.39%
    AstraZeneca Weighs Direct-To-Patient Drug Sales In US
    AstraZeneca Weighs Direct-To-Patient Drug Sales In US
    NDTV Profit
    Earlier this month, fellow European drugmaker Roche Holding AG said it was looking into direct sales to bypass players like pharmacy benefit managers.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.
    logo
    Piramal Pharma Ltd.
    29 Jul 2025
    187.73
    -3.83%
    Funding in bio-pharma sector still uncertain and inconsistent: Piramal Pharma Chairperson
    Business Line
    Says Piramal has earmarked about $120 million this year for capacity expansion
    Copy LinkShare onShare on Share on Share on
    Piramal Pharma Ltd. is trading below all available SMAs
    Piramal Pharma Q1 Results: Net Loss At Rs 82 Crore, Revenue Falls
    NDTV Profit | 29 Jul 2025 1 more
    Piramal Pharma Q1 net loss at 82 crore
    Business Line | 29 Jul 2025
    logo
    Piramal Pharma Ltd.
    29 Jul 2025
    187.73
    -3.83%
    Piramal Pharma sees US CDMO softness, eyes $2 billion topline by FY30
    Business Standard
    US biotech funding slowdown hits Piramal's CDMO business as company expands sterile injectables facility and maintains long-term growth targets
    Copy LinkShare onShare on Share on Share on
    Piramal Pharma Ltd. has an average target of 262.67 from 3 brokers.
    logo
    Strides Pharma Science Ltd.
    29 Jul 2025
    815.50
    -2.85%
    Strides Pharma Profit Rises 81% To Rs 114 Crore In June Quarter
    Strides Pharma Profit Rises 81% To Rs 114 Crore In June Quarter
    NDTV Profit
    Revenue rose to Rs 1,120 crore for the June quarter against Rs 1,054 crore in the year-ago period, Strides Pharma Science said in a regulatory filing.
    Copy LinkShare onShare on Share on Share on
    Strides Pharma Science Ltd.'s price crossed below 100Day SMA today
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Jain Resource Recycling
    • Jinkushal Industries
    • Systematic Industries
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd